Sort
8,912 grants matching “sars cov 2”
Nevada IDeA Networks of Biomedical Research Excellence (INBRE): SARS-CoV-2 Surveillance Study
$547,500Jonathan E. Baker · University Of Nevada Reno · P20 · FY2022 · GM
AI-based platform for predicting emerging vaccine-escape variants and designing mutation-proof antibodies
$547,413Guowei Wei · Michigan State University · R01 · FY2025 · AI
Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung Injury
$547,143Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2017 · AI
Determinants of Coronavirus Fidelity in Replication and Pathogenesis
$547,101Mark R Denison · Vanderbilt University · R01 · FY2014 · AI
Flow cytometer Cell Sorter for Biosafety Level-3 Facility
$547,000Ankita Garg · University Of Georgia · S10 · FY2021 · OD
Betacoronaviruses: activation and antagonism of host innate immune responses
$546,599Susan R. Weiss · University Of Pennsylvania · R01 · FY2023 · AI
Systems Biology Modeling of Severe Community-Acquired Pneumonia
$546,261Richard G Wunderink · Northwestern University At Chicago · U19 · FY2024 · AI
Intensifying Community Referrals for Health: The SINCERE Intervention to Address COVID-19 Health Disparities
$546,104Andrea Schneider Wallace · University Of Utah · R01 · FY2024 · NR
Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence
$545,825Philip J Goulder · University Of Oxford · U01 · FY2022 · AI
Role of eicosanoids in pathogenic human CoV infections
$545,235Stanley Perlman · University Of Iowa · R01 · FY2020 · AI
Role of eicosanoids in pathogenic human CoV infections
$545,235Stanley Perlman · University Of Iowa · R01 · FY2018 · AI
Role of eicosanoids in pathogenic human CoV infections
$545,235Stanley Perlman · University Of Iowa · R01 · FY2017 · AI
Role of eicosanoids in pathogenic human CoV infections
$545,235Stanley Perlman · University Of Iowa · R01 · FY2019 · AI
Role of eicosanoids in pathogenic human CoV infections
$545,235Stanley Perlman · University Of Iowa · R01 · FY2016 · AI
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
$545,091Ignacio E. Sanz · Emory University · U54 · FY2022 · CA
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
$545,091Ignacio E. Sanz · Emory University · U54 · FY2022 · CA
Role of IRE1 Alpha in Coronavirus Infections
$544,713Susan Leilani Fink · University Of Washington · R01 · FY2023 · AI
Role of IRE1 Alpha in Coronavirus Infections
$544,713Susan Leilani Fink · University Of Washington · R01 · FY2022 · AI
Epidemiology and Genetics of Susceptibility to COVID-19 Infection
$544,689Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA
Improving the diagnosis and outcome of diffuse alveolar hemorrhage in systemic lupus erythematosus
$544,689Westley H Reeves · University Of Florida · R01 · FY2025 · AR
AI-based platform for predicting emerging vaccine-escape variants and designing mutation-proof antibodies
$544,602Guowei Wei · Michigan State University · R01 · FY2024 · AI
Development of therapeutics for SARS-CoV-2 infection
$544,510Hiroaki Mitsuya · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
CORALE-SeroNet Project 1
$544,446Jane C. Figueiredo · Cedars-Sinai Medical Center · U54 · FY2020 · CA
Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung Injury
$544,376Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2021 · AI
Structural and Functional Characterization of SARS-CoV-2 RNA Processing Factors
$544,255Robin Stanley · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES